China has escalated its trade war with the U.S. by raising tariffs on American goods to 125% from 84% in response to President Trump’s increase of U.S. tariffs on Chinese imports to an effective rate of 145%.
The Chinese finance ministry stated that such high tariffs render U.S. goods uncompetitive in China and warned that further U.S. tariff hikes would be ignored. Both nations appear to have reached a peak in tariff escalation, with no immediate plans for further increases. Economist Zhiwei Zhang suggests that the focus will now shift to assessing economic damage and potential disruptions to global supply chains, with no indication of imminent negotiations.
Notably, China has not introduced additional export controls or expanded its “unreliable entity list” targeting U.S. firms, diverging from previous retaliatory tactics.
GDEX posts weak 1QFY26 results, but restructuring and GD Xchange growth support long‑term outlook; BUY…
Kerjaya Prospek Group Bhd’s net profit in 1QFY26 increased by 24.5%, boosted by construction division…
FBM KLCI rebounds on tech gains, tracking global optimism, though geopolitical risks and oil prices…
The government has disbursed RM4bil under its RM15bil PowerUp 10K financing initiative, benefiting over 150,000…
More Malaysian women in finance are pursuing entrepreneurship, strengthening SME growth, innovation, leadership diversity, and…
Partnership integrates Sandoz biosimilars into Alpro Pharmacy’s OncoHelp programme to support patients from government hospitals…
This website uses cookies.